Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of eleven abstracts covering research in amyotrophic lateral sclerosis (ALS) at the 2025 Muscular Dystrophy Association ...
Results demonstrated statistically significant effects on biomarkers that predict ALS disease progression and severity Evidence of brain pe ...
New Cross-Regimen Analysis of HEALEY ALS Platform Trial Shows Significant Survival AdvantageSALT LAKE CITY, March 12, 2025 (GLOBE NEWSWIRE) -- Clene, Inc. (Nasdaq: CLNN) and its subsidiary, Clene ...
AKGsOVIHAMS, a leading healthcare institution, has marked progress in treating ALS using integrative medicine. Known for combining conventional and alternative therapies, the institute has shown ...
Startup Cognixion, which has developed a noninvasive brain-computer interface, has begun a clinical trial for patients with ...
Singer Roberta Flack dies, 88. Harlem's Abyssinian Church memorializes her March 10th with a public 'Celebration of Life.' ...
Despite being diagnosed with Amyotrophic Lateral Sclerosis, or ALS, a longtime coach at Northern Bedford County High School ...
A new study compares three types of blood biomarkers: neurofilament light chain proteins, glial acidic proteins and phosphorylated tau 181.
For decades, scientists have focused on amyloid plaques—abnormal clumps of misfolded proteins that accumulate between neurons ...
Pathmaker's MyoRegulator is designed to ease hyperexcitability and delivers an electrical current to the spinal cord and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback